Immunitas Therapeutics

$500.0K revenue • 21 Hickory Dr, Waltham, MA, 02451, United States

Last Updated Feb 19, 2026

Company Overview

Company Name

Immunitas Therapeutics

Address

21 Hickory Dr, Waltham, MA, 02451, United States

Approx. Annual Revenue

$0.5M

Established

2019

About Immunitas Therapeutics

Immunitas is a biopharmaceutical company based in Waltham, Massachusetts, focused on developing novel therapeutics for cancer and autoimmune diseases. Their lead program, IMT-009, targets CD161 and is in clinical trials for various indications. Immunitas is led by an experienced team and backed by a strong scientific advisory board.

Frequently Asked Questions about Immunitas Therapeutics

Technologies Used

Social Profiles

Key Decision Makers

Amanda Wagner CEO
LinkedIn
Erika Manyak Senior Clinical Trial Manager
LinkedIn